Yumanity Therapeutics (YMTX) Short Interest Ratio & Short Volume → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free YMTX Stock Alerts $0.62 -0.05 (-7.46%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Yumanity Therapeutics Short Interest DataCurrent Short Volume46,100 sharesPrevious Short Volume50,300 sharesChange Vs. Previous Month-8.35%Dollar Volume Sold Short$82,519.00Short Interest Ratio / Days to Cover0.6Last Record DateNovember 30, 2022Outstanding Shares10,856,000 sharesPercentage of Shares Shorted0.42%Today's Trading Volume172,143 sharesAverage Trading Volume473,083 sharesToday's Volume Vs. Average36% Short Selling Yumanity Therapeutics ? Sign up to receive the latest short interest report for Yumanity Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatYMTX Short Interest Over TimeYMTX Days to Cover Over TimeYMTX Percentage of Float Shorted Over Time Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> Yumanity Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202246,100 shares $82,519.00 -8.4%N/A0.6 $1.79 11/15/202250,300 shares $91,546.00 -25.2%N/A1.4 $1.82 10/31/202267,200 shares $112,224.00 -14.4%0.8%2.2 $1.67 10/15/202278,500 shares $131,880.00 +31.1%0.9%2.1 $1.68 9/30/202259,900 shares $94,043.00 -2.9%0.7%1.5 $1.57 9/15/202261,700 shares $107,975.00 -21.3%0.7%1.2 $1.75 Get the Latest News and Ratings for YMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Yumanity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202278,400 shares $134,064.00 +32.4%0.9%1 $1.71 8/15/202259,200 shares $96,496.00 -12.7%0.7%0.1 $1.63 7/31/202267,800 shares $109,836.00 -27.1%0.8%0.1 $1.62 7/15/202293,000 shares $159,960.00 -34.3%1.1%0.1 $1.72 6/30/2022141,500 shares $257,530.00 -62.1%1.8%0.1 $1.82 6/15/2022373,000 shares $604,260.00 +216.6%4.6%0.3 $1.62 5/31/2022117,800 shares $124,868.00 -14.6%1.5%0.1 $1.06 5/15/2022138,000 shares $165,600.00 +25.5%1.7%0.3 $1.20 4/30/2022110,000 shares $121,000.00 -6.3%1.4%0.3 $1.10 4/15/2022117,400 shares $167,882.00 -70.6%1.5%0.3 $1.43 3/31/2022398,600 shares $597,900.00 +837.9%5.1%0.9 $1.50 3/15/202242,500 shares $45,050.00 +13.9%0.6%0.1 $1.06 2/28/202237,300 shares $42,522.00 +1.1%0.5%0.4 $1.14 2/15/202236,900 shares $64,944.00 -27.9%0.5%0.4 $1.76 1/31/202251,200 shares $99,840.00 -18.5%0.8%0.3 $1.95 1/15/202262,800 shares $170,188.00 +22.7%0.9%0.4 $2.71 12/31/202151,200 shares $151,552.00 -16.3%0.8%0.3 $2.96 12/15/202161,200 shares $189,108.00 -61.4%0.9%0.3 $3.09 11/30/2021158,400 shares $666,864.00 -1.6%2.3%0.7 $4.21 11/15/2021160,900 shares $839,898.00 +53.8%2.3%0.8 $5.22 10/29/2021104,600 shares $957,090.00 +45.7%1.5%0.7 $9.15 10/15/202171,800 shares $634,712.00 -2.3%1.0%0.5 $8.84 9/30/202173,500 shares $758,520.00 -59.9%1.1%0.5 $10.32 9/15/2021183,300 shares $2.10 million +25.2%2.7%1.3 $11.45 8/31/2021146,400 shares $1.58 million -46.5%2.1%1.4 $10.80 8/13/2021273,800 shares $2.65 million +3.1%4.0%2.5 $9.67 7/30/2021265,500 shares $2.41 million -32.8%3.9%2.6 $9.08 7/15/2021394,900 shares $4.04 million -4.0%6.0%4.3 $10.23 6/30/2021411,500 shares $4.79 million +13.4%6.3%5.2 $11.65 6/15/2021363,000 shares $5.45 million -1.3%5.5%5 $15.02 5/28/2021367,900 shares $5.66 million -5.9%5.6%5.8 $15.38 5/14/2021390,900 shares $5.54 million -1.3%5.9%7.5 $14.18 4/30/2021396,100 shares $6.69 million -6.0%6.0%6.1 $16.89 4/15/2021421,400 shares $7.38 million -12.8%5.9%6.1 $17.52top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… YMTX Short Interest - Frequently Asked Questions What is Yumanity Therapeutics' current short interest? Short interest is the volume of Yumanity Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 46,100 shares of YMTX short. Learn More on Yumanity Therapeutics' current short interest. What is a good short interest ratio for Yumanity Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. YMTX shares currently have a short interest ratio of 1.0. Learn More on Yumanity Therapeutics's short interest ratio. Is Yumanity Therapeutics' short interest increasing or decreasing? Yumanity Therapeutics saw a drop in short interest during the month of November. As of November 30th, there was short interest totaling 46,100 shares, a drop of 8.3% from the previous total of 50,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Yumanity Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Yumanity Therapeutics: Adial Pharmaceuticals, Inc. (0.24%), Cadrenal Therapeutics, Inc. (0.50%), Protagenic Therapeutics, Inc. (0.32%), Tenax Therapeutics, Inc. (2.62%), Clever Leaves Holdings Inc. (1.15%), Trevena, Inc. (0.63%), eFFECTOR Therapeutics, Inc. (10.72%), Enveric Biosciences, Inc. (4.23%), Shuttle Pharmaceuticals Holdings, Inc. (0.72%), Kazia Therapeutics Limited (1.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.93 billion), Suncor Energy Inc. ($3.50 billion), T. Rowe Price Group, Inc. ($2.29 billion), PG&E Co. ($1.73 billion), Coinbase Global, Inc. ($1.71 billion), Etsy, Inc. ($1.65 billion), Paramount Global ($1.54 billion), Lucid Group, Inc. ($1.50 billion), Old Dominion Freight Line, Inc. ($1.46 billion), and DICK'S Sporting Goods, Inc. ($1.41 billion). View all of the most shorted stocks. What does it mean to sell short Yumanity Therapeutics stock? Short selling YMTX is an investing strategy that aims to generate trading profit from Yumanity Therapeutics as its price is falling. YMTX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Yumanity Therapeutics? A short squeeze for Yumanity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YMTX, which in turn drives the price of the stock up even further. How often is Yumanity Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YMTX, twice per month. The most recent reporting period available is November, 30 2022. More Short Interest Resources from MarketBeat Related Companies: Adial Pharmaceuticals Short Interest Cadrenal Therapeutics Short Interest Protagenic Therapeutics Short Interest Tenax Therapeutics Short Interest Clever Leaves Short Interest Trevena Short Interest eFFECTOR Therapeutics Short Interest Enveric Biosciences Short Interest Shuttle Pharmaceuticals Short Interest Kazia Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:YMTX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith